Iterum Therapeutics plc (ITRMF) Intangibles (2021 - 2025)

Iterum Therapeutics has reported Intangibles for 5 years, with the latest figure at $18.7 million in Q3 2025.

• On a quarterly basis, Intangibles changed N/A year-over-year to $18.7 million in Q3 2025; TTM through Sep 2025 was $18.7 million, a N/A change from a year earlier, with the FY2024 full-year figure at $19.7 million, changed N/A from the prior year.
• Intangibles was $18.7 million for Q3 2025 at Iterum Therapeutics, down from $19.1 million in the prior quarter.
• The five-year high for Intangibles was $19.7 million in Q4 2024, with the low at $432000.0 in Q3 2023.
• Average Intangibles over 5 years is $7.7 million, with a median of $2.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Intangibles sank 49.96% in 2022, then sank 79.89% in 2023.
• Over 5 years, Intangibles stood at $3.4 million in 2021, then slumped by 49.96% to $1.7 million in 2022, then sank by 74.87% to $432000.0 in 2023, then surged by 4470.83% to $19.7 million in 2024, then declined by 5.25% to $18.7 million in 2025.
• The last three Intangibles figures came in at $18.7 million (Q3 2025), $19.1 million (Q2 2025), and $19.4 million (Q1 2025), per Business Quant data.